Patent · US Active

Anti-angiogenic peptides and uses thereof

US10034913B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

HEALTH RESEARCH, INC. · US

Inventors

Kailash C. Chadha · Williamsville, US
Gary J. Smith · Kingston, CA

Key dates

Filing date	Aug 4, 2015
Grant date	Jul 31, 2018
Priority date	—
Expiry date	Aug 4, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are peptide sequences derived from prostate serum antigen (PSA). The peptides are provided in cyclic and linear form. Methods for using the peptides for inhibition of angiogenesis, such as angiogenesis in a tumor, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.